ANGLE plc

LSE:AGL.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

📊 Big Data

💻 Computers

🩺 Medical Instruments

💻 Telehealth

Location

United Kingdom

Market Cap

USD 35.38 M

Share Price

USD 0.10

Avg Daily Volume

1,244,720

Change (1 day)

-0.13%

Change (1 year)

-44.08%

Change (YTD)

-21.35%

ANGLE plc Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: -0.83

ANGLE plc Enterprise Value to EBITDA (EV/EBITDA) is -0.83 on June 20, 2025, a -52.60% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

ANGLE plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -0.62 on June 20, 2025, which is 25.43% above the current Enterprise Value to EBITDA (EV/EBITDA).
ANGLE plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -2.08 on June 20, 2025, which is -151.06% below the current Enterprise Value to EBITDA (EV/EBITDA).
ANGLE plc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -1.25.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

LSE: AGL.L

ANGLE plc

CEO	Mr. Andrew David William Newland ACA, Meng
IPO Date	March 17, 2004
Location	United Kingdom
Headquarters	Surrey Research Park
Employees	150
Sector	🏥 Health Care
Industries Biotechnology 📊 Big Data 💻 Computers 🩺 Medical Instruments 💻 Telehealth

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.